The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 778K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

7 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
1
HETEROCYCLIC COMPOUND AS TYK2 INHIBITOR, AND SYNTHESIS AND USE THEREOFBDB
Zhejiang Wenda Pharmaceutical Technology
62
TYK2 INHIBITORS AND USES THEREOFBDB
Alumis
6
COMPOUND AS TYK2/JAK1 PSEUDOKINASE DOMAIN INHIBITOR, AND SYNTHESIS AND USE METHODSBDB
Zhejiang Wenda Pharmaceutical Technology
13
Aza-indazole compounds for use in tendon and/or ligament injuriesBDB
Novartis
28
Heterocyclyl-substituted cyclohexylsulfonamides as JAK inhibitorsBDB
Elanco Tiergesundheit
69
Compounds and methods for inhibiting JAKBDB
Dizal (Jiangsu) Pharmaceutical
13
Substituted indazoles for treating tendon and/or ligament injuriesBDB
Novartis